Novelix Pharma.

Market Cap: Micro Cap
Industry: Retailing
ISIN: INE314I01036
NSEID:
BSEID: 536565
View on BSE

INR

79.00

-0.76 (-0.95%)

BSENSE

Sep 02, 12:45 PM

BSE+NSE Vol: 948

{
  "main_header": {
    "sid": 200695,
    "name": "Novelix Pharma.",
    "stock_name": "Novelix Pharma.",
    "full_name": "Novelix Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/novelix-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "79.00",
    "chg": -0.76,
    "chgp": "-0.95%",
    "dir": -1,
    "prev_price": "79.76",
    "mcapval": "227.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 536565,
    "symbol": "",
    "ind_name": "Retailing",
    "ind_code": 4,
    "sector_id": 72,
    "indexname": "India SENSEX",
    "isin": "INE314I01036",
    "curr_date": "Sep 02, 12:45 PM",
    "curr_time": "13:20 PM",
    "last_traded_at": "Sep 02, 12:45 PM IST",
    "bse_nse_vol": "948 ",
    "exc_status": "Active",
    "traded_date": "Sep 02, 2026",
    "traded_date_str": "2026 09 02",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novelix-pharma-200695-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Novelix Pharmaceuticals Downgraded to Hold Amid Mixed Technical and Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-downgraded-to-hold-amid-mixed-technical-and-financial-signals-4178905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NovelixPharmace_mojoScore_4178905.png",
        "date": "2026-09-02 08:16:54",
        "description": "Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen its investment rating downgraded from Buy to Hold as of 1 September 2026. This adjustment reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust sales growth and impressive long-term returns, emerging technical signals and valuation concerns have tempered enthusiasm among analysts."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-buy-4175835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_mojoScore_4175835.png",
        "date": "2026-08-31 10:10:57",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-valuation-shifts-signal-changing-market-sentiment-4166338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_valuationdot_4166338.png",
        "date": "2026-08-24 08:00:09",
        "description": "Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating. This change reflects evolving market perceptions amid robust stock performance and a mixed financial profile, prompting investors to reassess its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Novelix Pharmaceuticals Gains 1.87%: 2 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-gains-187-2-key-factors-driving-the-week-4166157",
        "imagepath": "",
        "date": "2026-08-23 14:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>17 Aug:</strong> Stock opens at Rs.73.31, down 4.67% amid broader market weakness</p>\n                    <p><strong>18 Aug:</strong> Valuation re-rating announced, signalling renewed price attractiveness</p>\n                    <p><strong>19 Aug:</strong> Downgrade to Hold rating issued amid mixed financial and technical signals</p>\n                    <p><strong>21 Aug:</strong> Week closes at Rs.78.34, up 1.87% for the week, outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.73.31</div></div>\n                    <div class=\"stat-item..."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-downgraded-to-hold-amid-mixed-financial-and-technical-signals-4160552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_mojoScore_4160552.png",
        "date": "2026-08-19 08:13:06",
        "description": "Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen its investment rating downgraded from Buy to Hold as of 18 Aug 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite robust financial performance and market-beating returns, evolving technical signals and valuation metrics have prompted a more cautious stance."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-buy-4159404",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_mojoScore_4159404.png",
        "date": "2026-08-18 10:10:57",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4158431",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_valuationdot_4158431.png",
        "date": "2026-08-18 08:00:17",
        "description": "Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling improved price attractiveness for investors within the retailing sector. This change, coupled with robust returns relative to the Sensex, positions the micro-cap stock as a compelling opportunity amid evolving market conditions."
      },
      {
        "title": "When is the next results date for Novelix Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-novelix-pharmaceuticals-ltd-4148857",
        "imagepath": "",
        "date": "2026-08-11 23:18:54",
        "description": "The next results date for Novelix Pharmaceuticals Ltd is scheduled for 13 August 2026...."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4141713",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_mojoScore_4141713.png",
        "date": "2026-08-07 10:10:03",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 13 February 2026. While this rating change occurred earlier this year, the analysis and financial metrics discussed here reflect the stock's current position as of 07 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 149,
    "sid": "200695",
    "stock_news_url": "https://www.marketsmojo.com/news/novelix-pharmaceuticals-200695"
  },
  "announcements": [
    {
      "caption": "Shareholders Meeting AGM On 30Th September 2026.",
      "datetime": "31-Aug-2026",
      "details": "Submission of Intimation of AGM Date.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "31-Aug-2026",
      "details": "Submission of intimation of change in Designation of Director.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 29Th August 2026",
      "datetime": "29-Aug-2026",
      "details": "Submission of outcome of the board meeting.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has declared <strong>3%</strong> dividend, ex-date: 16 Aug 12",
          "dt": "2012-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has announced <strong>10:1</strong> stock split, ex-date: 04 Oct 10",
          "dt": "2010-10-04",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Novelix Pharmaceuticals Downgraded to Hold Amid Mixed Technical and Financial Signals

2026-09-02 08:16:54

Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen its investment rating downgraded from Buy to Hold as of 1 September 2026. This adjustment reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust sales growth and impressive long-term returns, emerging technical signals and valuation concerns have tempered enthusiasm among analysts.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Buy

2026-08-31 10:10:57

Novelix Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd Valuation Shifts Signal Changing Market Sentiment

2026-08-24 08:00:09

Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating. This change reflects evolving market perceptions amid robust stock performance and a mixed financial profile, prompting investors to reassess its price attractiveness relative to peers and historical benchmarks.

Read full news article

Novelix Pharmaceuticals Gains 1.87%: 2 Key Factors Driving the Week

2026-08-23 14:00:06

Key Events This Week

17 Aug: Stock opens at Rs.73.31, down 4.67% amid broader market weakness

18 Aug: Valuation re-rating announced, signalling renewed price attractiveness

19 Aug: Downgrade to Hold rating issued amid mixed financial and technical signals

21 Aug: Week closes at Rs.78.34, up 1.87% for the week, outperforming Sensex

Week Open

Rs.73.31

Read full news article

Novelix Pharmaceuticals Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals

2026-08-19 08:13:06

Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen its investment rating downgraded from Buy to Hold as of 18 Aug 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite robust financial performance and market-beating returns, evolving technical signals and valuation metrics have prompted a more cautious stance.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Buy

2026-08-18 10:10:57

Novelix Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-18 08:00:17

Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling improved price attractiveness for investors within the retailing sector. This change, coupled with robust returns relative to the Sensex, positions the micro-cap stock as a compelling opportunity amid evolving market conditions.

Read full news article

When is the next results date for Novelix Pharmaceuticals Ltd?

2026-08-11 23:18:54

The next results date for Novelix Pharmaceuticals Ltd is scheduled for 13 August 2026....

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-08-07 10:10:03

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 13 February 2026. While this rating change occurred earlier this year, the analysis and financial metrics discussed here reflect the stock's current position as of 07 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.